COVID-19 vaccines for kids ages 5 to 11 could be ready as soon as next week

By: - October 25, 2021 4:26 pm

Data from Pfizer that was analyzed by FDA regulators indicates that the company’s vaccine would offer strong protection. The two-shot regime had a 90.7 percent efficacy rate in preventing symptomatic COVID-19 in a clinical trial of children ages 5 to 11 (Getty Images).

Our stories may be republished online or in print under Creative Commons license CC BY-NC-ND 4.0. We ask that you edit only for style or to shorten, provide proper attribution and link to our web site. Please see our republishing guidelines for use of photos and graphics.

Laura Olson
Laura Olson

Laura covers the nation's capital as a senior reporter for States Newsroom, a network of nonprofit outlets that includes The Missouri Independent. Her areas of coverage include politics and policy, lobbying, elections, and campaign finance.

MORE FROM AUTHOR